Skip to main content
Year archive

Genmab — 2017 filings

All 124 regulatory filings released by Genmab (GMAB) in 2017, sourced directly from the official regulator.

124 Filings
2017 Period
2017 filings (124)
Filing Released Lang
Director's Dealing 2017
Director's Dealing
2017-12-15 English
Capital/Financing Update 2017
Capital/Financing Update
2017-11-29 English
Genmab Achieves USD 20 Million Milestone in Daratumumab Collaboration with Janssen and Updates Financial Guidance
Earnings Release FY 2017
2017-11-29 English
Regulatory Filings 2017
Regulatory Filings
2017-11-21 English
Genmab Announces Submission of Supplemental Biologics License Application to FDA for Daratumumab in Front Line Multiple Myeloma
Regulatory Filings
2017-11-21 English
Regulatory Filings 2017
Regulatory Filings
2017-11-21 English
Genmab Announces European Regulatory Submission for Daratumumab in Front Line Multiple Myeloma
Regulatory Filings
2017-11-21 English
Earnings Release 2017
Earnings Release FY 2017
2017-11-17 English
Genmab Achieves USD 50 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen
Regulatory Filings
2017-11-17 English
Earnings Release 2017
Earnings Release FY 2017
2017-11-14 English
Genmab Achieves USD 25 Million Milestone for First Commercial Sale of DARZALEX® (daratumumab) in Japan and Updates Financial Guidance
Regulatory Filings
2017-11-14 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2017-11-14 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2017-11-14 English
Major Shareholding Notification 2017
Major Shareholding Notification
2017-11-09 English
Major Shareholder Announcement
Major Shareholding Notification
2017-11-09 English
Interim / Quarterly Report 2017
Interim / Quarterly Report 9M 2017
2017-11-08 English
Genmab Announces Financial Results for the First Nine Months of 2017
Interim / Quarterly Report 9M 2017
2017-11-08 English
Regulatory Filings 2017
Regulatory Filings
2017-10-24 English
Genmab Announces Additional Information Concerning Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2017
Regulatory Filings
2017-10-24 English
Earnings Release 2017
Earnings Release Q3 2017
2017-10-17 English
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2017
Earnings Release Q3 2017
2017-10-17 English
Legal Proceedings Report 2017
Legal Proceedings Report
2017-10-10 English
Genmab and Seattle Genetics to Initiate New Study of Novel Antibody-Drug Conjugate Tisotumab Vedotin in Cervical Cancer
Regulatory Filings
2017-10-10 English
Remuneration Information 2017
Remuneration Information
2017-10-05 English
Grant of Restricted Stock Units and Warrants to Genmab employees
Share Issue/Capital Change
2017-10-05 English
Regulatory Filings 2017
Regulatory Filings
2017-09-27 English
Genmab Announces Approval of DARZALEX® (daratumumab) for Relapsed or Refractory Multiple Myeloma in Japan
Regulatory Filings
2017-09-27 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2017-09-26 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2017-09-26 English
Regulatory Filings 2017
Regulatory Filings
2017-08-29 English
Genmab and Seattle Genetics to Co-develop Tisotumab Vedotin for Solid Tumors
Regulatory Filings
2017-08-29 English
Regulatory Filings 2017
Regulatory Filings
2017-08-24 English
Genmab Announces Positive Topline Results in Phase III ALCYONE Study of Daratumumab in Front Line Multiple Myeloma
Regulatory Filings
2017-08-24 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2017-08-15 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2017-08-15 English
Earnings Release 2017
Earnings Release H1 2017
2017-08-09 English
Genmab Announces Financial Results for the First Half of 2017
Earnings Release H1 2017
2017-08-09 English
Earnings Release 2017
Earnings Release Q2 2017
2017-07-18 English
Earnings Release 2017
Earnings Release Q2 2017
2017-07-18 English
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2017
Earnings Release Q2 2017
2017-07-18 English
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2017
Earnings Release Q2 2017
2017-07-18 English
Director's Dealing 2017
Director's Dealing
2017-07-04 English
Director's Dealing 2017
Director's Dealing
2017-06-28 English
Director's Dealing 2017
Director's Dealing
2017-06-27 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2017-06-27 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2017-06-27 English
Regulatory Filings 2017
Regulatory Filings
2017-06-16 English
Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Combination with Pomalidomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma
Regulatory Filings
2017-06-16 English
Regulatory Filings 2017
Regulatory Filings
2017-06-16 English
Genmab Announces Preliminary Cervical Cancer Data from Tisotumab Vedotin Phase I/II Study
Regulatory Filings
2017-06-16 English
Regulatory Filings 2017
Regulatory Filings
2017-06-08 English
Regulatory Filings 2017
Regulatory Filings
2017-06-08 English
Grant of Restricted Stock Units and Warrants to Genmab employees
Share Issue/Capital Change
2017-06-08 English
Regulatory Filings 2017
Regulatory Filings
2017-05-17 English
Genmab Announces Plans for New Studies of Daratumumab
Regulatory Filings
2017-05-17 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2017-05-16 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2017-05-16 English
Interim / Quarterly Report 2017
Interim / Quarterly Report Q1 2017
2017-05-10 English
Genmab Announces Financial Results for the First Quarter of 2017
Interim / Quarterly Report Q1 2017
2017-05-10 English
Legal Proceedings Report 2017
Legal Proceedings Report
2017-04-28 English
Genmab Announces New Phase III Combination Study of Daratumumab in Multiple Myeloma
Regulatory Filings
2017-04-28 English
Regulatory Filings 2017
Regulatory Filings
2017-04-28 English
Genmab Announces European Marketing Authorization for DARZALEX® (daratumumab) for Relapsed or Refractory Multiple Myeloma
Regulatory Filings
2017-04-28 English
Earnings Release 2017
Earnings Release Q1 2017
2017-04-18 English
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2017
Regulatory Filings
2017-04-18 English
Director's Dealing 2017
Director's Dealing
2017-04-05 English
Director's Dealing 2017
Director's Dealing
2017-04-04 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2017-04-04 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2017-04-04 English
Regulatory Filings 2017
Regulatory Filings
2017-03-30 English
Regulatory Filings 2017
Regulatory Filings
2017-03-30 Danish
Fase II studie med daratumumab til behandling af non-Hodgkin lymfom videreføres ikke til del 2
Regulatory Filings
2017-03-30 English
Fase II studie med daratumumab til behandling af non-Hodgkin lymfom videreføres ikke til del 2
Regulatory Filings
2017-03-30 English
Director's Dealing 2017
Director's Dealing
2017-03-29 English
Director's Dealing 2017
Director's Dealing
2017-03-29 Danish
Remuneration Information 2017
Remuneration Information
2017-03-29 Danish
Remuneration Information 2017
Remuneration Information
2017-03-29 English
Tildeling af restricted stock units til to nye bestyrelsesmedlemmer og tildeling af restricted stock units og warrants til en ny direktør i Genmab
Remuneration Information
2017-03-29 English
Tildeling af restricted stock units til to nye bestyrelsesmedlemmer og tildeling af restricted stock units og warrants til en ny direktør i Genmab
Share Issue/Capital Change
2017-03-29 English
AGM Information 2017
AGM Information
2017-03-28 English
AGM Information 2017
AGM Information
2017-03-28 Danish
Konstitution af bestyrelsen i Genmab A/S og tildeling af restricted stock units og warrants til medarbejdere i Genmab
Regulatory Filings
2017-03-28 English
Konstitution af bestyrelsen i Genmab A/S og tildeling af restricted stock units og warrants til medarbejdere i Genmab
Share Issue/Capital Change
2017-03-28 English
Director's Dealing 2017
Director's Dealing
2017-03-01 English
Director's Dealing 2017
Director's Dealing
2017-03-01 Danish
Director's Dealing 2017
Director's Dealing
2017-02-28 Danish
Director's Dealing 2017
Director's Dealing
2017-02-28 English
Kapitalforhøjelse i Genmab som følge af udnyttelse af medarbejderwarrants
Share Issue/Capital Change
2017-02-28 English
Kapitalforhøjelse i Genmab som følge af udnyttelse af medarbejderwarrants
Share Issue/Capital Change
2017-02-28 English
Kapitalforhøjelse i Genmab som følge af udnyttelse af medarbejderwarrants
Share Issue/Capital Change
2017-02-28 English
Kapitalforhøjelse i Genmab som følge af udnyttelse af medarbejderwarrants
Share Issue/Capital Change
2017-02-28 Danish
Regulatory Filings 2017
Regulatory Filings
2017-02-27 English
Regulatory Filings 2017
Regulatory Filings
2017-02-27 Danish
Indkaldelse til ordinær generalforsamling i Genmab A/S
Proxy Solicitation & Information Statement
2017-02-27 English
Indkaldelse til ordinær generalforsamling i Genmab A/S
Proxy Solicitation & Information Statement
2017-02-27 English
Regulatory Filings 2017
Regulatory Filings
2017-02-24 English
Regulatory Filings 2017
Regulatory Filings
2017-02-24 English
CHMP afgiver positiv udtalelse og anbefaler DARZALEX® (daratumumab) til behandling af recidiverende eller refraktær myelomatose
Regulatory Filings
2017-02-24 English
CHMP afgiver positiv udtalelse og anbefaler DARZALEX® (daratumumab) til behandling af recidiverende eller refraktær myelomatose
Regulatory Filings
2017-02-24 Danish
Annual Report 2017
Annual Report
2017-02-23 Danish
Annual Report 2016
Annual Report FY 2016
2017-02-23 English
Genmab 2016 Annual Report
Report Publication Announcement
2017-02-22 English
Genmab 2016 Annual Report
Annual Report FY 2016
2017-02-22 English
Genmab 2016 Annual Report
Report Publication Announcement
2017-02-22 English
Share Issue/Capital Change 2017
Share Issue/Capital Change
2017-02-10 English
Share Issue/Capital Change 2017
Share Issue/Capital Change
2017-02-10 English
Tildeling af restricted stock units og warrants til medarbejdere i Genmab
Share Issue/Capital Change
2017-02-10 English
Tildeling af restricted stock units og warrants til medarbejdere i Genmab
Share Issue/Capital Change
2017-02-10 Danish
Regulatory Filings 2017
Regulatory Filings
2017-02-08 Danish
Regulatory Filings 2017
Regulatory Filings
2017-02-08 English
Genmab ansætter Judith Klimovsky, MD, som Chief Development Officer
Board/Management Information
2017-02-08 English
Genmab ansætter Judith Klimovsky, MD, som Chief Development Officer
Board/Management Information
2017-02-08 English
Earnings Release 2016
Earnings Release FY 2016
2017-02-06 Danish
Earnings Release 2016
Earnings Release FY 2016
2017-02-06 English
Genmab opdaterer resultatforventningerne til 2016
Earnings Release FY 2016
2017-02-06 English
Genmab opdaterer resultatforventningerne til 2016
Earnings Release FY 2016
2017-02-06 English
Earnings Release 2016
Earnings Release FY 2016
2017-01-24 English
Earnings Release 2016
Earnings Release FY 2016
2017-01-24 Danish
Genmab offentliggør nettoomsætningen for DARZALEX® (daratumumab) i 2016
Earnings Release FY 2016
2017-01-24 English
Genmab offentliggør nettoomsætningen for DARZALEX® (daratumumab) i 2016
Regulatory Filings
2017-01-24 English
M&A Activity 2017
M&A Activity
2017-01-06 English
Regulatory Filings 2017
Regulatory Filings
2017-01-06 English
Genmab når salgsmilestone på USD 25 mio. i samarbejdet med Janssen om DARZALEX® (daratumumab)
Regulatory Filings
2017-01-06 English
Genmab når salgsmilestone på USD 25 mio. i samarbejdet med Janssen om DARZALEX® (daratumumab)
Regulatory Filings
2017-01-06 Danish